BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38668707)

  • 1. Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the
    Han Y; Buric A; Chintareddy V; DeMoss M; Chen L; Dickerhoff J; De Dios R; Chand P; Riggs R; Yang D; Cushman M
    J Med Chem; 2024 May; 67(9):7006-7032. PubMed ID: 38668707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the
    Wang KB; Elsayed MSA; Wu G; Deng N; Cushman M; Yang D
    J Am Chem Soc; 2019 Jul; 141(28):11059-11070. PubMed ID: 31283877
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
    Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors.
    Zhao Q; Xu X; Xie Z; Liu X; You Q; Guo Q; Zhong Y; Li Z
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1068-1072. PubMed ID: 26725027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
    Hu MH; Lin JH
    J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
    Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
    J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
    Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
    Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
    Elsayed MSA; Su Y; Wang P; Sethi T; Agama K; Ravji A; Redon CE; Kiselev E; Horzmann KA; Freeman JL; Pommier Y; Cushman M
    J Med Chem; 2017 Jul; 60(13):5364-5376. PubMed ID: 28657311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
    Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
    J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
    Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
    J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.
    Beck DE; Lv W; Abdelmalak M; Plescia CB; Agama K; Marchand C; Pommier Y; Cushman M
    Bioorg Med Chem; 2016 Apr; 24(7):1469-79. PubMed ID: 26906474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
    Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
    Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin analogs exhibit anti-cancer activity by selectively targeting G-quadruplex forming c-myc promoter sequence.
    Pandya N; Khan E; Jain N; Satham L; Singh R; Makde RD; Mishra A; Kumar A
    Biochimie; 2021 Jan; 180():205-221. PubMed ID: 33188859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Synthesis of Indenoisoquinolines Targeting Topoisomerase I and Other Biological Macromolecules for Cancer Chemotherapy.
    Cushman M
    J Med Chem; 2021 Dec; 64(24):17572-17600. PubMed ID: 34879200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
    Khadka DB; Park S; Jin Y; Han J; Kwon Y; Cho WJ
    Eur J Med Chem; 2018 Jan; 143():200-215. PubMed ID: 29174815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
    Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
    J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
    Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
    Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
    Shan C; Yan JW; Wang YQ; Che T; Huang ZL; Chen AC; Yao PF; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    J Med Chem; 2017 Feb; 60(4):1292-1308. PubMed ID: 28128954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.